Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate in Adults with ADHD
NCT02951754Phase 4Recruiting
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Feb 2002
- Primary completion
- Dec 2032
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoint: Self-reported changes in severity of ADHD symptoms at 1 year. Started Feb 2002; status: recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02951754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02951754.